361 related articles for article (PubMed ID: 16626885)
1. Impact of radiotherapy in the risk of esophageal cancer as subsequent primary cancer after breast cancer.
Salminen EK; Pukkala E; Kiel KD; Hakulinen TT
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):699-704. PubMed ID: 16626885
[TBL] [Abstract][Full Text] [Related]
2. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
3. Increased risk of squamous cell esophageal cancer after adjuvant radiation therapy for primary breast cancer.
Zablotska LB; Chak A; Das A; Neugut AI
Am J Epidemiol; 2005 Feb; 161(4):330-7. PubMed ID: 15692076
[TBL] [Abstract][Full Text] [Related]
4. Angiosarcoma after radiotherapy: a cohort study of 332,163 Finnish cancer patients.
Virtanen A; Pukkala E; Auvinen A
Br J Cancer; 2007 Jul; 97(1):115-7. PubMed ID: 17519906
[TBL] [Abstract][Full Text] [Related]
5. The risk of oesophageal cancer is not affected by a diagnosis of breast cancer.
Cooper SC; Croft S; Day R; Thomson CS; Trudgill NJ
Eur J Cancer Prev; 2010 May; 19(3):182-5. PubMed ID: 20145541
[TBL] [Abstract][Full Text] [Related]
6. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
[TBL] [Abstract][Full Text] [Related]
7. Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study.
Schaapveld M; Visser O; Louwman MJ; de Vries EG; Willemse PH; Otter R; van der Graaf WT; Coebergh JW; van Leeuwen FE
J Clin Oncol; 2008 Mar; 26(8):1239-46. PubMed ID: 18323547
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose and risk of soft tissue and bone sarcoma after breast cancer treatment.
Rubino C; Shamsaldin A; Lê MG; Labbé M; Guinebretière JM; Chavaudra J; de Vathaire F
Breast Cancer Res Treat; 2005 Feb; 89(3):277-88. PubMed ID: 15754127
[TBL] [Abstract][Full Text] [Related]
9. Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC; Hashibe M; Scelo G; Brewster DH; Pukkala E; Friis S; Tracey E; Weiderpass E; Hemminki K; Tamaro S; Chia KS; Pompe-Kirn V; Kliewer EV; Tonita JM; Martos C; Jonasson JG; Dresler CM; Boffetta P; Brennan P
Cancer Epidemiol Biomarkers Prev; 2008 Jun; 17(6):1543-9. PubMed ID: 18559572
[TBL] [Abstract][Full Text] [Related]
10. Increased breast cancer risk after radiotherapy for acne among women with skin cancer.
El-Gamal H; Bennett RG
J Am Acad Dermatol; 2006 Dec; 55(6):981-9. PubMed ID: 17097395
[TBL] [Abstract][Full Text] [Related]
11. Can we consider always an esophageal carcinoma as radiation associated cancer after irradiation for breast cancer?
Kirova YM; Asselain B; Fourquet A;
Am J Clin Oncol; 2009 Apr; 32(2):197-9. PubMed ID: 19346814
[TBL] [Abstract][Full Text] [Related]
12. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
Kaufman EL; Jacobson JS; Hershman DL; Desai M; Neugut AI
J Clin Oncol; 2008 Jan; 26(3):392-8. PubMed ID: 18202415
[TBL] [Abstract][Full Text] [Related]
13. Risk of second primary cancer among patients with early operable breast cancer registered or randomised in Danish Breast Cancer cooperative Group (DBCG) protocols of the 77, 82 and 89 programmes during 1977-2001.
Andersson M; Jensen MB; Engholm G; Henrik Storm H
Acta Oncol; 2008; 47(4):755-64. PubMed ID: 18465345
[TBL] [Abstract][Full Text] [Related]
14. Roles of radiotherapy and chemotherapy in the development of contralateral breast cancer.
Hooning MJ; Aleman BM; Hauptmann M; Baaijens MH; Klijn JG; Noyon R; Stovall M; van Leeuwen FE
J Clin Oncol; 2008 Dec; 26(34):5561-8. PubMed ID: 18854572
[TBL] [Abstract][Full Text] [Related]
15. Leukemia incidence following primary breast carcinoma treatment.
Kaplan HG; Malmgren JA; Atwood M
Cancer; 2004 Oct; 101(7):1529-36. PubMed ID: 15378478
[TBL] [Abstract][Full Text] [Related]
16. Second primary cancers in men with prostate cancer: an increased risk of male breast cancer.
Thellenberg C; Malmer B; Tavelin B; Grönberg H
J Urol; 2003 Apr; 169(4):1345-8. PubMed ID: 12629357
[TBL] [Abstract][Full Text] [Related]
17. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
[TBL] [Abstract][Full Text] [Related]
18. Lifelong cancer incidence in 47,697 patients treated for childhood cancer in the Nordic countries.
Olsen JH; Möller T; Anderson H; Langmark F; Sankila R; Tryggvadóttír L; Winther JF; Rechnitzer C; Jonmundsson G; Christensen J; Garwicz S
J Natl Cancer Inst; 2009 Jun; 101(11):806-13. PubMed ID: 19470947
[TBL] [Abstract][Full Text] [Related]
19. Malignant breast tumors after radiotherapy for a first cancer during childhood.
Guibout C; Adjadj E; Rubino C; Shamsaldin A; Grimaud E; Hawkins M; Mathieu MC; Oberlin O; Zucker JM; Panis X; Lagrange JL; Daly-Schveitzer N; Chavaudra J; de Vathaire F
J Clin Oncol; 2005 Jan; 23(1):197-204. PubMed ID: 15625374
[TBL] [Abstract][Full Text] [Related]
20. Carcinogenic effects of radiotherapy for breast cancer.
Neugut AI; Weinberg MD; Ahsan H; Rescigno J
Oncology (Williston Park); 1999 Sep; 13(9):1245-56; discussion 1257, 1261-5. PubMed ID: 10509322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
